Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
BRISTOL-MYERS SQUIBB CO. Add to My Watchlist (NYSE: BMY) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     BRISTOL-MYERS 24.25 +0.29 (+1.21%) 9,906,506
345 Park Avenue
New York, NY 10154 US
(212) 546-4000
(212) 546-4020 fax
www.bms.com
CEO James M. Cornelius
Auditor DELOITTE & TOUCHE LLP
Exchange Traded NY
ISIN Number US1101221083
CIK Number 14272
NAICS Code 325412
Business Summary
A global biopharmaceutical company, which through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical and nutritional products.
Number of Employees 35,000
Share Fundamentals
Market Cap 48.04B
Shares Outstanding 1.98B
Float 1.98B
Short Interest 139.04M
Financial Strength
Revenue (TTM) $18,808,000,000
Earnings (TTM) $11,862,000,000
Quick Ratio 1.4:1
Current Ratio 1.8:1
Total Debt/Equity 0.45:1
Dividend Information
Yield % 5.3
Annual Dividend 1.28
Latest Dividend 1.28 (2009-12-30)
Profitability
Gross Margin 75.1%
EBITDA Margin 27.9%
Profit Margin 36.2%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs